The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line serplulimab and bevacizumab combined with nab-paclitaxel/gemcitabine followed by mFOLFOX in advanced pancreatic cancer: A phase II trial.
 
Jieer Ying
No Relationships to Disclose
 
Qi Xu
No Relationships to Disclose
 
Jingjing Li
No Relationships to Disclose
 
Qing Wei
No Relationships to Disclose
 
Lei Zhang
No Relationships to Disclose
 
Shurui Zhou
No Relationships to Disclose
 
Meifang Zheng
No Relationships to Disclose
 
Yunben Yang
No Relationships to Disclose